Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
Brady James Aloysius received 24,193 Xeris Biopharma Holdings, Inc. shares as an award (Form 4)
Traded Jun 4, 2026 · Filed Jun 5, 2026
On Jun 4, 2026, Brady James Aloysius (Director) received 24,193 Xeris Biopharma Holdings, Inc. shares as an award, leaving 113,359 shares. Filed Jun 5, 2026 (Form 4).
- Awarded
- 24,193 shares
- Holding after
- 113,359 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Award | 24,193 | 113,359 | Direct |
Source
Related
- Xeris Biopharma Holdings, Inc.
- Brady James Aloysius
- Xeris Biopharma Holdings, Inc. shareholders
- Form 4 · Brady James Aloysius · Apr 1, 2026
- Form 4 · Hecht Beth · Oct 2, 2026
- Form 4 · McCulloch Kevin · Oct 2, 2026
- Form 4 · Pieper Steven · Oct 2, 2026
- Form 4 · McCulloch Kevin · Sep 29, 2026
- Form 4 · McCulloch Kevin · Sep 1, 2026